Company: MVIS
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001641172-25-022632
Chunk: 106

Company: MICROVISION, INC.
Filing Date: 2025-08-08
Form: 10-Q
Item: Part I, Item 8
Chunk 106
---
 operating activities
of $39.4 million during the same period in 2024. Cash used in operating activities resulted primarily from cash used to fund our net
loss, after adjusting for non-cash charges such as share-based compensation, intangible impairment expense, depreciation and amortization
charges and changes in operating assets and liabilities. The changes in cash used in operating activities were primarily attributed to
decreased operating expenses related to personnel. We expect to make minimum payments to our contract manufacturing partner in connection
with the production of MOVIA sensor inventory of approximately $2.3 million during the remainder of 2025 and 2026 in line with agreed-upon
deliveries.

Investing
activities

During
the six months ended June 30, 2025, net cash provided by investing activities was $2.8 million compared to net cash used in investing
activities of $7.4 million during the same period in 2024. During the six months ended June 30, 2025, we purchased short-term investment
securities totaling $19.3 million and sold short-term investment securities totaling $22.4 million, compared to purchases of $23.5 million
and sales of $22.7 million in the same period of 2024. During the six months ended June 30, 2024,
we made payments totaling $6.3 million related to the acquisition of Ibeo assets.

26

Financing
activities

Net
cash provided by financing activities totaled $43.3 million during the six months ended June 30, 2025, compared to net cash provided
by financing activities of $26.2 million during the same period of 2024. Net proceeds from issuance of common stock and warrants
were $43.3 million during six months ended June 30, 2025 compared to $26.1 million during the same period in 2024. Proceeds received
from stock option exercises totaled $0.1 million during the six months ended June 30, 2024.

The
following is a list of our financing activities during 2025 and 2024.

●In
                                            February 2025, we entered into a securities purchase agreement for the purchase of 5,750,225
                                            shares of our common stock and warrants to purchase 5,750,225 shares of our common stock
                                            for $1.57 per share. We received proceeds, net of all costs, of $7.8 million